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The goals of antidepressant treatment are to induce remis-
sion and prevent relapse or recurrence. While response is
the standard criterion applied to comparisons of antide-
pressant drugs indicating an improvement from baseline,
the more stringent criterion of remission is more relevant
to clinical practice because it indicates that the patient is
symptom-free. Studies with many antidepressants dem-
onstrate response rates up to 60% but remission rates less
than 30%.
Co-occurring somatic symptoms are suggested as risk fac-
tors predispose to low remission rates. 50% of depressed
patients report pain while many different types of pain
occur more frequently in people with depression than in
non-depressed control populations. Pain and depression
may share common pathways and may both respond to
treatment with certain antidepressants. Selection of opti-
mal antidepressant therapy should consider drugs that
have the greatest potential to induce remission. It is
important to evaluate antidepressants in terms of its effi-
cacy in relation to that of reference agents such as the tri-
cyclics, SSRI's and MAOI's.
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